Crossmark Global Holdings’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,119
Closed -$212K 1288
2022
Q3
$212K Sell
10,119
-160
-2% -$3.33K 0.01% 1150
2022
Q2
$214K Buy
10,279
+110
+1% +$1.96K 0.01% 1187
2022
Q1
$170K Buy
+10,169
New +$178K ﹤0.01% 1316
2021
Q3
Sell
-8,989
Closed -$243K 1443
2021
Q2
$243K Buy
8,989
+42
+0.5% +$1.18K 0.01% 1286
2021
Q1
$268K Buy
8,947
+110
+1% +$3.75K 0.01% 1234
2020
Q4
$254K Hold
8,837
0.01% 1184
2020
Q3
$216K Buy
+8,837
New +$191K 0.01% 1193
2019
Q3
Sell
-8,354
Closed -$204K 1385
2019
Q2
$204K Sell
8,354
-196
-2% -$5.65K 0.01% 1295
2019
Q1
$272K Buy
+8,550
New +$303K 0.01% 1165

Other funds holding CVET

Crossmark Global Holdings's CVET Position: Q4 2022 in Review

Crossmark Global Holdings sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 10,119 shares — an estimated $212K sold.

Crossmark Global Holdings first reported a position in CVET in Q1 2019 and held it in 9 quarters. The position peaked at $272K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Crossmark Global Holdings reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 10,119 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $212K.
  • Crossmark Global Holdings first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Crossmark Global Holdings's Covetrus, Inc. Common Stock position peaked at $272K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Crossmark Global Holdings's 13F filing for Q4 2022, filed 19 Jan 2023.